RECOMBINANT IMMUNOTOXIN AIMED AT MESOTHELIN Russian patent published in 2016 - IPC C07K19/00 C07K16/30 C07K14/21 A61K39/00 

Abstract RU 2600067 C2

FIELD: biochemistry.

SUBSTANCE: invention relates to biochemistry, particularly to an improved recombinant immunotoxin for the cells expressing mesothelin. Disclosed immunotoxin is a fused protein containing the antibody to mesothelin and Pseudomonas exotoxin fragment which is modified to reduce its immunogenicity and sensitivity to proteases. Immunotoxin can be used in the method for treatment of cancer overexpressing mesothelin.

EFFECT: invention provides high cytotoxicity of immunotoxin in relation to the cells expressing mesothelin.

21 cl, 9 dwg, 4 tbl, 2 ex

Similar patents RU2600067C2

Title Year Author Number
EXOTOXIN A PSEUDOMONAS WITH LESS IMMUNOGENIC T-AND/OR B-CELL EPITHOPES 2012
  • Pastan Ira Kh.
  • Mazor Ronit
  • Onda Massanori
  • Vassall Eron
  • Biers Richard
  • Eberle Khajme
  • Lyu Venkhaj
RU2627216C2
MODIFIED EXOTOXIN A PSEUDOMONADES 2014
  • Pastan Ira Kh.
  • Mazor Ronit
  • Onda Masanori
  • Li Byunkuk
  • Niderfellner Gerkhard
  • Imkhof-Yung Zabine
  • Brinkmann Ulrikh
  • Georges Gaj
RU2687143C2
CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF 2014
  • Bitti Gregori
  • Engels Boris
  • Idamakanti Neeradzha
  • Dzhun Karl Kh.
  • Lev Andreas
  • Sun Khuejtszyuan
  • U Tsilun
RU2714902C2
NK-CELL ACTIVATING FUSED PROTEIN, NK-CELLS AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM 2018
  • Kim, Seok Ho
  • Lee, Jaemin
  • Cho, Duck
RU2740438C1
SINGLE-CHAIN ANTIBODIES AND OTHER HETEROMULTIMERS 2013
  • Vranik Bernd
  • Iton Den L.
  • Kristensen Erin Kh.
  • Vu Tszyanshen
RU2644341C2
CANCER TREATMENT USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANISED ANTI-EGFRvIII ANTIBODY 2014
  • Brogdon Dzhennifer
  • Dzhonson Laura Aleksandra
  • Dzhun Karl Kh.
  • Lev Andreas
  • Maus Marsela
  • Sholler Dzhon
  • Okada Khidekho
RU2708032C2
INTERFERON PRODRUG FOR CANCER TREATMENT 2018
  • Fu, Yang-Xin
  • Cao, Xuezhi
RU2788736C2
DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST LYME DISEASE 2017
  • Weiner, David, B.
  • Flingai, Seleeke
RU2813829C2
THERAPEUTIC AGENTS AND METHODS FOR THE TREATMENT OF TLR2-MEDIATED DISEASES AND DISORDERS 2019
  • Witztum, Joseph, L.
  • Tsimikas, Sotirios
  • Que, Xuchu
RU2791022C2
GLYCAN-DEPENDENT IMMUNOTHERAPY MOLECULES 2016
  • Demetriou Majkl
  • Chzhou Rejmond Venkhou
RU2754661C2

RU 2 600 067 C2

Authors

Pastan Ira Kh.

Veldon Dzhon

Biers Richard

Dates

2016-10-20Published

2012-05-04Filed